NEW YORK and SHANGHAI, July 23, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it will release its financial results for the sec

PHILADELPHIA, July 23, 2019 /PRNewswire/ -- Tridiuum, the leading provider of digital health solutions for accelerating behavioral and medical care integration, today announced its CFO, Ed Camarota, has been named CFO of the Year by the Philadelphia Business Journal. Camarota joins an exclusive class of financial leaders r

ANAHEIM, Calif., July 23, 2019 /PRNewswire/ -- On September 10-12, 2019, Clinical Operations Week will commence at the Anaheim Marriott (700 W. Convention Way) and will include three specialized conferences:

NEW YORK, July 23, 2019 /PRNewswire/ -- Xylyx Bio, a pioneer in physiomimetic biomaterials, today announced that it has joined the

DALLAS, July 23, 2019 /PRNewswire/ -- DoctorLogic, the creators of the all-in-one Website Marketing Platform exclusively for healthcare providers, is proud to announce the launch of its newly redesigned website at

TEL AVIV, Israel, July 23, 2019 /PRNewswire/ -- RSIP Vision, a global leader in artificial intelligence (AI), computer vision, and image processing technology, has announced the release of an advanced AI lung segmentation module that reduces the threat of false positives in biopsies. The new solution helps refine a common yet intricate procedure in which mistakes ar

CAMBRIDGE, Mass., July 23, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, July 30, 2019 at 8:00 a.m. ET to review its second quarter 2019 financial results and provide an update on the company. A live webcast of the conference call

NEW YORK, July 23, 2019 /PRNewswire/ -- The Mesothelioma Victims Center is urging a family that just lost their loved one from confirmed mesothelioma before they had a chan

GAITHERSBURG, Md., July 23, 2019 /PRNewswire/ -- MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it has appointed Dr. Dhana Chinnasamy, a 20+-year expert in the research and translation of gene and immunotherapies, as its Vice President, Non-Clinical and Translational Studi

RANCHO CORDOVA, Calif., July 23, 2019 /PRNewswire/ -- ThermoGenesis, a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL) and a market leader in automated cellular processing, today announced that